Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105

Event date: 2025-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Shay Capital LLC

    Shares: 810,214.00 · Class: 6.3%

  • Shay Capital Holdings LLC

    Shares: 810,214.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001723643-25-000011
Form type
SCHEDULE 13G
Filer
OnKure Therapeutics, Inc.
CIK
CIK 1637715
Filed
May 29, 2025
Reporting period
May 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub